Radical accelerated radiotherapy for non-small cell lung cancer (NSCLC): A 5-year retrospective review of two dose fractionation schedules-Reference-Cited by-同舟云学术

Radical accelerated radiotherapy for non-small cell lung cancer (NSCLC): A 5-year retrospective review of two dose fractionation schedules

Published:2020-02 Issue: Volume:143 Page:37-43
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Robinson Stephen D.^ORCID,Tahir Bilal A.^ORCID,Absalom Katherine A.R.,Lankathilake Amila,Das Tathagata,Lee Caroline,Fisher Patricia M.,Bates Emma,Hatton Matthew Q.F.^ORCID

Funder

Yorkshire Cancer Research Senior Fellowship

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference31 articles.

1. 40-year trends in an index of survival for all cancers combined and survival adjusted for age and sex for each cancer in England and Wales, 1971–2011: a population-based study;Quaresma;Lancet,2015

2. Meta-analysis of concomitant versus sequential radio-chemotherapy in locally advanced non-small-cell lung cancer;Aupérin;J Clin Oncol,2010

3. Dose and fractionation in radiation therapy for curative intent for non-small cell lung cancer: meta-analysis of randomised trials;Ramroth;Int J Radiat Once Biol Phys,2016

4. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study

5. Eligibility for concurrent chemotherapy and radiotherapy of locally advanced lung cancer patients: a prospective, population-based study;De Ruysscher;Ann Oncol,2009

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neue radioonkologische Therapiekonzepte beim nicht metastasierten Lungenkarzinom;Zentralblatt für Chirurgie - Zeitschrift für Allgemeine, Viszeral-, Thorax- und Gefäßchirurgie;2024-08

2. Evidence-based clinical recommendations for hypofractionated radiotherapy: exploring efficacy and safety - Part 2. Lung (non-small cell lung cancer);Radiation Oncology Journal;2024-06-30

3. Efficiency of moderately hypofractionated radiotherapy in NSCLC cell model;Frontiers in Oncology;2024-04-24

4. Explainable deep learning-based survival prediction for non-small cell lung cancer patients undergoing radical radiotherapy;Radiotherapy and Oncology;2024-04

5. miR-338-3p acts as a tumor suppressor in lung squamous cell carcinoma by targeting FGFR2/FRS2;Cancer Pathogenesis and Therapy;2023-04